FerGene Company
FerGene is a newly established company that emerged as a spin-off from Ferring Pharmaceuticals. Its main purpose is to develop and market the gene therapy called nadofaragne firadenovec in the United States and to further its clinical development worldwide.
Headquarters:
Saint-prex, Vaud
Funding Status:
Private Equity
Estimated Revenue:
$1M to $10M
Technology:
Neurological Disorders
Founded Date:
2019
Industry:
Gene Therapy